Skip to content

Central pancreatectomy versus traditional body and tail pancreatectomy combined with splenectomy in patients with early pancreatic cancer: a prospective, randomized, controlled clinical study

Central pancreatectomy versus traditional body and tail pancreatectomy combined with splenectomy in patients with early pancreatic cancer: a prospective, randomized, controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102062
Enrollment
Unknown
Registered
2025-05-08
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early cervical pancreatic cancer

Interventions

Observation group:Central pancreatectomy
Control group:traditional pancreatic body and tail combined with splenectomy

Sponsors

The Affiliated BenQ Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-80 years old;2.According to clinical symptoms, imaging examination, tumor markers and other auxiliary examinations before surgery and postoperative pathology, it was determined that the tumor size was <= 2 cm, the tumor was located in the neck or tail of the pancreas, and the tumor was enhanced without lymph nodes or distant metastasis, and the diagnosis was early T1 stage pancreatic neck cancer or pancreatic body and tail cancer; 3. No surgical contraindications, able to tolerate radical surgery;4. Compliance with the study plan and follow-up procedure; 5. Obtain informed consent signed by the patient or his or her legal agent.

Exclusion criteria

Exclusion criteria: 1. Malignant tumors in other areas within the last 5 years; Patients with brain, lung, bone metastases or abdominal lymph node metastases; 2. patients with severe cardiopulmonary function, liver and renal function infection; 3. Infection of HCV, HIV, syphilis; 4. Women during pregnancy or lactation.5.Patients who required pancreaticoduodenectomy or total pancreatectomy before surgery based on clinical symptoms, imaging examination, tumor markers and other auxiliary examinations; 6.Prior pancreaticoduodenectomy was performed.

Design outcomes

Primary

MeasureTime frame
Tumor R0 resection rate;The incidence of short-term postoperative complications;Recurrence-free survival time;Overall survival rate;

Secondary

MeasureTime frame
Hemoglobin A1c level;The usage of oral hypoglycemic drugs and insulin after the operation;Hospitalization expenses;Postoperative hospital stay days;

Countries

China

Contacts

Public ContactYi Miao

Nanjing Medical Affiliated BenQ Hospital University

miaoyi@njmu.edu.cn+86 158 0518 9988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026